Quick Answer
KESTRA MEDICAL TECHNOLOGIES, LTD. reported Earnings Per Share Diluted of $5.13 (loss) per share for the year ending 2025.
- KESTRA MEDICAL TECHNOLOGIES, LTD. showed a decrease of -1.2% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from KESTRA MEDICAL TECHNOLOGIES, LTD.'s annual report (Form 10-K), filed with the SEC on July 17, 2025.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2024: $1.12 (loss) per share | Q4 2024: $1.19 (loss) per share | Q1 2025: $1.25 (loss) per share | Q3 2025: $0.50 (loss) per share | Q4 2025: $0.64 (loss) per share | Q1 2026: $0.61 (loss) per share.
- Historical annual values: Fiscal year 2025: $5.13 (loss) per share | Fiscal year 2024: $5.07 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: